The patient was a 39-year-old female with a history of NF1 who presented with an enlarging mass in the right arm with worsening radial nerve palsy
targeted the notoriously resistant bacterial biofilms that complicate CRS
We have also shown that they prevent the build-up of proteins associated with Alzheimers disease (at least in animal models), but the effect appears to be protective against future disease, rather than active disease. Key takeaways All of this points towards these drugs being protective for a number of diseases, many of which are driven by inflammation, says Dr Cork
Answers on semaglutide and tirzepatide, candidacy, dosing, compounded safety, and what to expect on a GLP-1 protocol
Other research peptides in this category Research articles and insights related to GLP-3 RT Why GLP-3 RT outperforms single and dual incretin agonists in preclinical research models comes down to the glucagon receptor component, energy expenditure, and integrated metabolic axis engagement
Cereda E, Barichella M, Cassani E, Caccialanza R, Pezzoli G